Download PDF
CC BY-NC-ND 4.0 · Journal of Social Health and Diabetes 2016; 04(02): 057-066
DOI: 10.4103/2321-0656.187996
Review Article
NovoNordisk Education Foundation

Fighting cancer through an informed society

Prashant Mehta
1   Unit Head Department of Medical Oncology/Hematoncology/BMT Asian Institute of Medical Sciences, Faridabad, Haryana, India
,
Pranjit Santonu Bhajoni
2   Department of Pharmacology, Ram Manohar Lohia Medical College and Hospital, New Delhi, India
,
Swati Pabbi Mehta
3   Department of Pathology, Sardar Patel Medical College, Bikaner, Rajasthan, India
› Author Affiliations
Further Information

Publication History

Publication Date:
23 November 2018 (online)

   Permissions and Reprints

Abstract

Social perceptions play an extremely important role in the lives of cancer patients and survivors. Society is a machinery which can dictate the behavioral pattern of a patient, the kind of treatment he/she seeks or believes in, and the treatment he/she finally takes. Proper education of the society, in general, with regard to various aspects of cancer and its treatment can make things easier for patients, their families and the treating physicians alike. False social beliefs create unsurmountable hurdles for both patients and their families. When families of cancer patients visit a doctor, very often they tend to describe the experience of one or more of their close or distant family members with cancer. They start reliving the same experience if it was bad, or they may develop a false sense of security about the curability if it was good. In both situations, it becomes difficult for them to understand that each cancer is different from the other, cancer being a heterogenous disease. Moreover, what the patients and their families hear from friends and their social support system about cancer in general makes them depressed, anxious, and vulnerable. The information they get from the Internet and print media is mostly unregulated and may present extreme views which compound their problems. In this review, we have analyzed some of the common perceptions and myths which we come across in clinical practice and have presented scientific data to refute or support these beliefs wherever suitable.

Cancer - myths - social perceptions - society
 

  • References

  • 1 Robb KA, Simon AE, Miles A, Wardle J. Public perceptions of cancer: A qualitative study of the balance of positive and negative beliefs. BMJ Open 2014; 4: e005434
    CrossrefPubMedGoogle Scholar
  • 2 Gilbar O, Hevroni A. Counterfactuals, coping strategies and psychological distress among breast cancer patients. Anxiety Stress Coping 2007; 20: 383-392
    CrossrefPubMedGoogle Scholar
  • 3 Mahal A, Karan A, Fan VY, Engelgau M. The economic burden of cancers on Indian households. PLoS One 2013; 8: e71853
    CrossrefPubMedGoogle Scholar
  • 4 Zellmer V, Zhang S. Evolving concepts of tumor heterogeneity. Cell Biosci 2014; 4: 69
    CrossrefPubMedGoogle Scholar
  • 5 Haque R, Ahmed SA, Inzhakova G, Shi J, Avila C, Polikoff J. et al. Impact of breast cancer subtypes and treatment on survival: An analysis spanning two decades. Cancer Epidemiol Biomarkers Prev 2012; 21: 1848-1855
    CrossrefPubMedGoogle Scholar
  • 6 Christ GH, Messner C, Behar LC. Handbook of Oncology Social Work: Psychosocial Care for People with Cancer. Oxford University Press; Incorporated; 2015
    Google Scholar
  • 7 Veal GJ, Coulthard SA, Boddy AV. Chemotherapy individualization. Invest New Drugs 2003; 21: 149-156
    CrossrefPubMedGoogle Scholar
  • 8 Byrd JC. Introduction to a series of reviews on chronic lymphocytic leukemia. Blood 2015; 126: 427
    CrossrefPubMedGoogle Scholar
  • 9 United States Cancer Statistics. Available from: https://www.nccd.cdc.gov/uscs/SurvivalData.aspx [Last cited on 2016 Jul 22].
    Google Scholar
  • 10 Park SJ, Woo SJ, Park KH. Incidence of retinoblastoma and survival rate of retinoblastoma patients in Korea using the Korean National Cancer Registry database (1993-2010). Invest Ophthalmol Vis Sci 2014; 55: 2816-2821
    CrossrefPubMedGoogle Scholar
  • 11 Davidoff AM. Wilms' tumor. Curr Opin Pediatr 2009; 21: 357-364
    CrossrefPubMedGoogle Scholar
  • 12 Koren J, Trnený M. Hodgkin×s lymphoma – The treatment approaches development and current trends. Klin Onkol 2015; 28 (Suppl. 03) 3S87-3S94
    CrossrefPubMedGoogle Scholar
  • 13 Székely E, Hagberg O, Arnljots K, Jerkeman M. Improvement in survival of diffuse large B-cell lymphoma in relation to age, gender, International Prognostic Index and extranodal presentation: A population based Swedish Lymphoma Registry study. Leuk Lymphoma 2014; 55: 1838-1843
    CrossrefPubMedGoogle Scholar
  • 14 Trigg ME, Sather HN, Reaman GH, Tubergen DG, Steinherz PG, Gaynon PS. et al. Ten-year survival of children with acute lymphoblastic leukemia: A report from the Children's Oncology Group. Leuk Lymphoma 2008; 49: 1142-1154
    CrossrefPubMedGoogle Scholar
  • 15 Brenner H, Gondos A, Pulte D. Trends in long-term survival of patients with chronic lymphocytic leukemia from the 1980s to the early 21st century. Blood 2008; 111: 4916-4921
    CrossrefPubMedGoogle Scholar
  • 16 Yee K, O'Brien S. Chronic lymphocytic leukemia/small lymphocytic lymphoma. In: O'Brien S, Vose J, Kantarjian H. Management of Hematologic Malignancies. 1st ed.. Cambridge University Press: Cambridge; 2010: 81-102
    CrossrefGoogle Scholar
  • 17 Olszewski AJ, Castillo JJ. Survival of patients with marginal zone lymphoma: Analysis of the surveillance, epidemiology, and end results database. Cancer 2013; 119: 629-638
    CrossrefPubMedGoogle Scholar
  • 18 Arcaini L, Rattotti S, Gotti M, Luminari S. Prognostic assessment in patients with indolent B-cell lymphomas. ScientificWorldJournal 2012; 2012: 107892
    PubMedGoogle Scholar
  • 19 Oza A, Rajkumar S. Waldenstrom macroglobulinemia: Prognosis and management. Blood Cancer J 2015; 5: e296
    PubMedGoogle Scholar
  • 20 Tangen CM, Faulkner JR, Crawford ED, Thompson IM, Hirano D, Eisenberger M. et al. Ten-year survival in patients with metastatic prostate cancer. Clin Prostate Cancer 2003; 2: 41-45
    CrossrefPubMedGoogle Scholar
  • 21 Li L, Shi YH, Guo ZJ, Qiu T, Guo L, Yang HY. et al. Clinicopathological features and prognosis assessment of extranodal follicular dendritic cell sarcoma. World J Gastroenterol 2010; 16: 2504-2519
    CrossrefPubMedGoogle Scholar
  • 22 Franceschi S, Arniani S, Balzi D, Geddes M. Survival of classic Kaposi's sarcoma and risk of second cancer. Br J Cancer 1996; 74: 1812-1814
    CrossrefPubMedGoogle Scholar
  • 23 Furtado M, Rule S. Indolent mantle cell lymphoma. Haematologica 2011; 96: 1086-1088
    CrossrefPubMedGoogle Scholar
  • 24 Van Eeden S, Quaedvlieg PF, Taal BG, Offerhaus GJ, Lamers CB, Van Velthuysen ML. Classification of low-grade neuroendocrine tumors of midgut and unknown origin. Hum Pathol 2002; 33: 1126-1132
    CrossrefPubMedGoogle Scholar
  • 25 Modrek AS, Hsu HC, Leichman CG, Du KL. Radiation therapy improves survival in rectal small cell cancer – Analysis of surveillance epidemiology and end results (SEER) data. Radiat Oncol 2015; 10: 101
    CrossrefPubMedGoogle Scholar
  • 26 Bernard M, Gressin R, Lefrère F, Drénou B, Branger B, Caulet-Maugendre S. et al. Blastic variant of mantle cell lymphoma: A rare but highly aggressive subtype. Leukemia 2001; 15: 1785-1791
    CrossrefPubMedGoogle Scholar
  • 27 Schorb E, Kasenda B, Atta J, Kaun S, Morgner A, Hess G. et al. Prognosis of patients with primary central nervous system lymphoma after high-dose chemotherapy followed by autologous stem cell transplantation. Haematologica 2013; 98: 765-770
    CrossrefPubMedGoogle Scholar
  • 28 Musk AW, Olsen N, Alfonso H, Reid A, Mina R, Franklin P. et al. Predicting survival in malignant mesothelioma. Eur Respir J 2011; 38: 1420-1424
    CrossrefPubMedGoogle Scholar
  • 29 Ramlov A, Tietze A, Khalil AA, Knap MM. Prophylactic cranial irradiation in patients with small cell lung cancer. A retrospective study of recurrence, survival and morbidity. Lung Cancer 2012; 77: 561-566
    CrossrefPubMedGoogle Scholar
  • 30 Johnson C. Prognosis in pancreatic cancer. Lancet 1997; 349: 1027
    CrossrefPubMedGoogle Scholar
  • 31 Konstantinidis I, Deshpande V, Genevay M, Ferrone C. Trends in presentation and survival for gallbladder cancer during a period of more than 4 decades. Arch Surg 2009; 144: 441
    Google Scholar
  • 32 Mathiesen T, Peredo I, Lönn S. Two-year survival of low-grade and high-grade glioma patients using data from the Swedish Cancer Registry. Acta Neurochir 2010; 153: 467-471
    PubMedGoogle Scholar
  • 33 Bennett JM, Young ML, Andersen JW, Cassileth PA, Tallman MS, Paietta E. et al. Long-term survival in acute myeloid leukemia: The Eastern Cooperative Oncology Group experience. Cancer 1997; 80 (Suppl. 11) 2205-2209
    CrossrefPubMedGoogle Scholar
  • 34 Onuigbo WIB. Human Behavior in Cancer Quackery: Historical Review. Int J Neurorehabilitation Eng 2016; 3: 196
    Google Scholar
  • 35 Goto S, Ino K, Mitsui T, Kikkawa F, Suzuki T, Nomura S. et al. Survival rates of patients with choriocarcinoma treated with chemotherapy without hysterectomy: Effects of anticancer agents on subsequent births. Gynecol Oncol 2004; 93: 529-535
    CrossrefPubMedGoogle Scholar
  • 36 Li J, Djenaba JA, Soman A, Rim SH, Master VA. Recent trends in prostate cancer incidence by age, cancer stage, and grade, the United States, 2001-2007. Prostate Cancer 2012; 2012: 691380
    PubMedGoogle Scholar
  • 37 Breast Cancer Survival Statistics. UK: Cancer Research; 2015 Available from: http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/breast-cancer/survival#heading-Two [Last cited on 2016 Jul 06].
    PubMedGoogle Scholar
  • 38 Anand P, Kunnumakkara AB, Sundaram C, Harikumar KB, Tharakan ST, Lai OS. et al. Cancer is a preventable disease that requires major lifestyle changes. Pharm Res 2008; 25: 2097-2116
    CrossrefPubMedGoogle Scholar
  • 39 Ellis C. Inherited Cancer Syndromes. New York: Springer; 2011
    Google Scholar
  • 40 Cancer Incidence by Age. UK: Cancer Research; 2015 Available from: http://www.cancerresearchuk.org/health-professional/cancer-statistics/incidence/age#heading-Zero [Last cited on 2016 Jul 06].
    PubMedGoogle Scholar
  • 41 Binder M, Roberts C, Spencer N, Antoine D, Cartwright C. On the antiquity of cancer: Evidence for metastatic carcinoma in a young man from ancient Nubia (c 1200 BC). PLoS One 2014; 9: e90924
    CrossrefPubMedGoogle Scholar
  • 42 Natarajan L, Melott A, Rothschild B, Martin L. Bone cancer rates in dinosaurs compared with modern vertebrates. Trans Kansas Acad Sci 2007; 110: 155-158
    CrossrefGoogle Scholar
  • 43 Bower M, Waxman J. Lecture Notes. Hoboken: John Wiley and Sons; 2011
    Google Scholar
  • 44 Lowy DR, Schiller JT. Reducing HPV-associated cancer globally. Cancer Prev Res (Phila) 2012; 5: 18-23
    CrossrefPubMedGoogle Scholar
  • 45 Watari J, Chen N, Amenta PS, Fukui H, Oshima T, Tomita T. et al. Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development. World J Gastroenterol 2014; 20: 5461-5473
    CrossrefPubMedGoogle Scholar
  • 46 Krcmery VJr. Emerging fungal infections in cancer patients. J Hosp Infect 1996; 33: 109-117
    CrossrefPubMedGoogle Scholar
  • 47 Rolston KV, Rodriguez S, Dholakia N, Whimbey E, Raad I. Pulmonary infections mimicking cancer: A retrospective, three-year review. Support Care Cancer 1997; 5: 90-93
    CrossrefPubMedGoogle Scholar
  • 48 Kato Y, Ozawa S, Miyamoto C, Maehata Y, Suzuki A, Maeda T. et al. Acidic extracellular microenvironment and cancer. Cancer Cell Int 2013; 13: 89
    CrossrefPubMedGoogle Scholar
  • 49 Bonjour JP. Nutritional disturbance in acid-base balance and osteoporosis: A hypothesis that disregards the essential homeostatic role of the kidney. Br J Nutr 2013; 110: 1168-1177
    CrossrefPubMedGoogle Scholar
  • 50 American Institute for Cancer Research (AICR) – EGEH: Busting Cancer Myths: Acidic Foods and Cancer Risks; 2016. Available from: http://www.preventcancer.aicr.org/site/News2?page=NewsArticle&id=13914&news_iv_ctrl=0&abbr=pr [Last cited on 2016 Jul 07].
    Google Scholar
  • 51 Michaud DS, Liu S, Giovannucci E, Willett WC, Colditz GA, Fuchs CS. Dietary sugar, glycemic load, and pancreatic cancer risk in a prospective study. J Natl Cancer Inst 2002; 94: 1293-1300
    CrossrefPubMedGoogle Scholar
  • 52 Bostick RM, Potter JD, Kushi LH, Sellers TA, Steinmetz KA, McKenzie DR. et al. Sugar, meat, and fat intake, and non-dietary risk factors for colon cancer incidence in Iowa women (United States). Cancer Causes Control 1994; 5: 38-52
    CrossrefPubMedGoogle Scholar
  • 53 Dong JY, Qin LQ. Dietary glycemic index, glycemic load, and risk of breast cancer: Meta-analysis of prospective cohort studies. Breast Cancer Res Treat 2011; 126: 287-294
    CrossrefPubMedGoogle Scholar
  • 54 De Pergola G, Silvestris F. Obesity as a major risk factor for cancer. J Obes 2013; 2013: 291546
    PubMedGoogle Scholar
  • 55 Gallus S, Scotti L, Negri E, Talamini R, Franceschi S, Montella M. et al. Artificial sweeteners and cancer risk in a network of case-control studies. Ann Oncol 2007; 18: 40-44
    PubMedGoogle Scholar
  • 56 Artificial Sweeteners and Cancer. National Cancer Institute; 2016 Available from: http://www.cancer.gov/about-cancer/causes-prevention/risk/diet/artificial-sweeteners-fact-sheet [Last cited on 2016 Jul 07].
    PubMedGoogle Scholar
  • 57 Mirick D. Antiperspirant Use and the Risk of Breast Cancer. Cancer Spectr Knowl Environ 2002; 94: 1578-1580
    Google Scholar
  • 58 Harling M, Schablon A, Schedlbauer G, Dulon M, Nienhaus A. Bladder cancer among hairdressers: A meta-analysis. Occup Environ Med 2010; 67: 351-358
    CrossrefPubMedGoogle Scholar
  • 59 Kelsh MA, Alexander DD, Kalmes RM, Buffler PA. Personal use of hair dyes and risk of bladder cancer: A meta-analysis of epidemiologic data. Cancer Causes Control 2008; 19: 549-558
    CrossrefPubMedGoogle Scholar
  • 60 Printz C. Breast cancer risk associated with HRT varies. Cancer 2014; 120: 315
    CrossrefPubMedGoogle Scholar
  • 61 Siegfried EC, Jaworski JC, Hebert AA. Topical calcineurin inhibitors and lymphoma risk: Evidence update with implications for daily practice. Am J Clin Dermatol 2013; 14: 163-178
    CrossrefPubMedGoogle Scholar
  • 62 Berger TG, Duvic M, Van Voorhees AS, VanBeek MJ, Frieden IJ. American Academy of Dermatology Association Task Force. The use of topical calcineurin inhibitors in dermatology: Safety concerns.Report of the American Academy of Dermatology Association Task Force. J Am Acad Dermatol 2006; 54: 818-823
    CrossrefPubMedGoogle Scholar
  • 63 Pöschl G, Seitz HK. Alcohol and cancer. Alcohol Alcohol 2004; 39: 155-165
    CrossrefPubMedGoogle Scholar
  • 64 Nelson DE, Jarman DW, Rehm J, Greenfield TK, Rey G, Kerr WC. et al. Alcohol-attributable cancer deaths and years of potential life lost in the United States. Am J Public Health 2013; 103: 641-648
    CrossrefPubMedGoogle Scholar
  • 65 Athar M, Back JH, Tang X, Kim KH, Kopelovich L, Bickers DR. et al. Resveratrol: A review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol 2007; 224: 274-283
    CrossrefPubMedGoogle Scholar
  • 66 Ekor M. The growing use of herbal medicines: Issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol 2014; 4: 177
    PubMedGoogle Scholar
  • 67 Childs O. Don't Believe the Hype – 10 Persistent Cancer Myths Debunked. UK: Cancer Research; 2016 Available from: http://www.scienceblog.cancerresearchuk.org/2014/03/24/dont-believe-the-hype-10-persistent-cancer-myths-debunked/ [Last cited 2016 Jul 07].
    PubMedGoogle Scholar
  • 68 Bashford EF. Cancer, credulity, and quackery. Br Med J 1911; 1: 1221-1230
    CrossrefPubMedGoogle Scholar
  • 69 Nolan G. Analysis: The Notion of Deliberate Suppression of the Cure for Cancer. The Logical Libertarian™; 2016 Available from: https://www.logicallibertarian.com/2016/05/26/analysis-the-notion-of-deliberate-suppression-of-the-cure-for-cancer/ [Last cited on 2016 Jul 07].
    PubMedGoogle Scholar
  • 70 Dawes L. “Just a quack who can cure cancer”: John Braund, and regulating cancer treatment in New South Wales, Australia. Med Hist 2013; 57: 206-225
    CrossrefPubMedGoogle Scholar
  • 71 Ostrander GK, Cheng KC, Wolf JC, Wolfe MJ. Shark cartilage, cancer and the growing threat of pseudoscience. Cancer Res 2004; 64: 8485-8491
    CrossrefPubMedGoogle Scholar
  • 72 Borucinska JD, Harshbarger JC, Bogicevic T. Hepatic cholangiocarcinoma and testicular mesothelioma in a wild-caught blue shark, Prionace glauca (L.). J Fish Dis 2003; 26: 43-49
    CrossrefPubMedGoogle Scholar
  • 73 Macneil J. Shark cartilage sinks in phase III lung cancer trial. Skin Allergy News 2007; 38: 48
    Google Scholar
  • 74 Vickers A. Alternative cancer cures: “Unproven” or “disproven”?. CA Cancer J Clin 2004; 54: 110-118
    CrossrefPubMedGoogle Scholar
  • 75 Research Groups – Section of Environment and Radiation; 2016. Available from: http://www.iarc.fr/en/research-groups/ENV/publications2.php [Last cited on 2016 Jul 07].
  • 76 Benson VS, Pirie K, Schüz J, Reeves GK, Beral V, Green J. Million Women Study Collaborators. Mobile phone use and risk of brain neoplasms and other cancers: Prospective study. Int J Epidemiol 2013; 42: 792-802
    CrossrefPubMedGoogle Scholar
  • 77 IARC. Non-ionizing Radiation, Part 2. Lyon: IARC; 2014
    Google Scholar
  • 78 Ahlbom A, Day N, Feychting M, Roman E, Skinner J, Dockerty J. et al. Apooled analysis of magnetic fields and childhood leukaemia. Br J Cancer 2000; 83: 692-698
    CrossrefPubMedGoogle Scholar
  • 79 Greenland S, Sheppard AR, Kaune WT, Poole C, Kelsh MA. A pooled analysis of magnetic fields, wire codes, and childhood leukemia. Childhood Leukemia-EMF Study Group. Epidemiology 2000; 11: 624-634
    CrossrefPubMedGoogle Scholar
  • 80 Kheifets L, Ahlbom A, Crespi CM, Draper G, Hagihara J, Lowenthal RM. et al. Pooled analysis of recent studies on magnetic fields and childhood leukaemia. Br J Cancer 2010; 103: 1128-1135
    CrossrefPubMedGoogle Scholar
  • 81 Swerdlow AJ. Health effects from radiofrequency electromagnetic fields. Didcot, Oxfordshire: National Radiological Protection Board; 2003
    Google Scholar
  • 82 Hatch EE, Linet MS, Kleinerman RA, Tarone RE, Severson RK, Hartsock CT. et al. Association between childhood acute lymphoblastic leukemia and use of electrical appliances during pregnancy and childhood. Epidemiology 1998; 9: 234-245
    CrossrefPubMedGoogle Scholar
  • 83 Findlay RP, Dimbylow PJ. SAR in a child voxel phantom from exposure to wireless computer networks (Wi-Fi). Phys Med Biol 2010; 55: N405-N411
    CrossrefPubMedGoogle Scholar
  • 84 Elliott P, Toledano M, Bennett J, Beale L, de Hoogh K, Best N. et al. Case-control Study of mobile phone base stations and early childhood cancers. Epidemiology 2011; 22: S52-S53
    Google Scholar
  • 85 Bellieni CV, Pinto I, Bogi A, Zoppetti N, Andreuccetti D, Buonocore G. Exposure to electromagnetic fields from laptop use of “laptop” computers. Arch Environ Occup Health 2012; 67: 31-36
    CrossrefPubMedGoogle Scholar
  • 86 Petticrew M, Bell R, Hunter D. Influence of psychological coping on survival and recurrence in people with cancer: Systematic review. BMJ 2002; 325: 1066
    CrossrefPubMedGoogle Scholar
  • 87 Mills GB. Genetic predisposition to cancer. In: Pollock RE. Hoboken. 8th ed.. New Jersey, USA: John Wiley and Sons; 2004: 63-89
    Google Scholar
  • 88 Giordano S. Breast cancer in men. Ann Intern Med 2002; 137: 678
    Google Scholar
  • 89 Guray M, Sahin AA. Benign breast diseases: Classification, diagnosis, and management. Oncologist 2006; 11: 435-449
    CrossrefPubMedGoogle Scholar
  • 90 Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M. et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005; 353: 1784-1792
    CrossrefPubMedGoogle Scholar
  • 91 Pharoah PD, Day NE, Duffy S, Easton DF, Ponder BA. Family history and the risk of breast cancer: A systematic review and meta-analysis. Int J Cancer 1997; 71: 800-809
    CrossrefPubMedGoogle Scholar
  • 92 Tam Ashing K, Padilla G, Tejero J, Kagawa-Singer M. Understanding the breast cancer experience of Asian American women. Psychooncology 2003; 12: 38-58
    CrossrefPubMedGoogle Scholar
  • 93 Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL. et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies. Am J Hum Genet 2003; 72: 1117-1130
    CrossrefPubMedGoogle Scholar
  • 94 Berg WA, Zhang Z, Lehrer D, Jong RA, Pisano ED, Barr RG. et al. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA 2012; 307: 1394-1404
    CrossrefPubMedGoogle Scholar
  • 95 Fisher B, Anderson S, Redmond CK, Wolmark N, Wickerham DL, Cronin WM. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1995; 333: 1456-1461
    CrossrefPubMedGoogle Scholar
  • 96 CDC – What Can I Do to Reduce My Risk of Breast Cancer? 2016. Available from: http://www.cdc.gov/cancer/breast/basic_info/prevention.htm [Last cited on 2016 Jul 07].
    Google Scholar
  • 97 Chen L, Malone KE, Li CI. Bra wearing not associated with breast cancer risk: A population-based case-control study. Cancer Epidemiol Biomarkers Prev 2014; 23: 2181-2185
    CrossrefPubMedGoogle Scholar
  • 98 Kasumi F. Problems in breast cancer screening. Jpn Med Assoc J 2005; 48: 301-309
    Google Scholar
  • 99 Caraceni A, Hanks G, Kaasa S, Bennett MI, Brunelli C, Cherny N. et al. Use of opioid analgesics in the treatment of cancer pain: Evidence-based recommendations from the EAPC. Lancet Oncol 2012; 13: e58-e68
    CrossrefPubMedGoogle Scholar
  • 100 Savage P. Development and economic trends in cancer therapeutic drugs in the UK from 1955 to 2009. J Oncol Pharm Pract 2012; 18: 52-56
    CrossrefPubMedGoogle Scholar
  • 101 Roila F, Ruggeri B, Ballatori E, Del Favero A, Tonato M. Aprepitant versus dexamethasone for preventing chemotherapy-induced delayed emesis in patients with breast cancer: A randomized double-blind study. J Clin Oncol 2013; 32: 101-106
    PubMedGoogle Scholar
  • 102 Saito M. Review of palonosetron in the prevention of chemotherapy-induced nausea and vomiting. Clin Med Rev Oncol 2010; 2: 209-220
    Google Scholar
  • 103 Pui C, Jeha S, Irwin D, Camitta B. Recombinant urate oxidase (rasburicase) in the prevention and treatment of malignancy-associated hyperuricemia in pediatric and adult patients: Results of a compassionate-use trial. Leukemia 2001; 15: 1505-1509
    CrossrefPubMedGoogle Scholar
  • 104 Mor V, Stalker MZ, Gralla R, Scher HI, Cimma C, Park D. et al. Day hospital as an alternative to inpatient care for cancer patients: A random assignment trial. J Clin Epidemiol 1988; 41: 771-785
    CrossrefPubMedGoogle Scholar
  • 105 Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016; 66: 7-30
    CrossrefPubMedGoogle Scholar
  • 106 Friedrichs K, Carstensen MH. Successful reduction of alopecia induced by anthracycline and taxane containing adjuvant chemotherapy in breast cancer – Clinical evaluation of sensor-controlled scalp cooling. Springerplus 2014; 3: 500
    CrossrefPubMedGoogle Scholar
  • 107 Kouvaris JR, Kouloulias VE, Vlahos LJ. Amifostine: The first selective-target and broad-spectrum radioprotector. Oncologist 2007; 12: 738-747
    CrossrefPubMedGoogle Scholar
  • 108 Choi M, Jiang PQ, Heilbrun LK, Smith DW, Gadgeel SM. Retrospective review of cancer patients > or =80 years old treated with chemotherapy at a comprehensive cancer center. Crit Rev Oncol Hematol 2008; 67: 268-72
    CrossrefPubMedGoogle Scholar
  • 109 Vento S, Cainelli F. Infections in patients with cancer undergoing chemotherapy: Aetiology, prevention, and treatment. Lancet Oncol 2003; 4: 595-604
    CrossrefPubMedGoogle Scholar
  • 110 Lyman GH, Kuderer NM, Djulbegovic B. Prophylactic granulocyte colony-stimulating factor in patients receiving dose-intensive cancer chemotherapy: A meta-analysis. Am J Med 2002; 112: 406-411
    CrossrefPubMedGoogle Scholar
  • 111 Zemlickis D, Lishner M, Degendorfer P, Panzarella T, Sutcliffe SB, Koren G. Fetal outcome after in utero exposure to cancer chemotherapy. Arch Intern Med 1992; 152: 573-576
    PubMedGoogle Scholar
  • 112 Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol 2004; 5: 283-291
    CrossrefPubMedGoogle Scholar
  • 113 Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH. et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2013; 31: 2500-2510
    CrossrefPubMedGoogle Scholar
  • 114 Engzell U, Esposti PL, Rubio C, Sigurdson A, Zajicek J. Investigation on tumour spread in connection with aspiration biopsy. Acta Radiol Ther Phys Biol 1971; 10: 385-398
    Google Scholar
  • 115 Rao A, Cohen HJ. Symptom management in the elderly cancer patient: Fatigue, pain, and depression. J Natl Cancer Inst Monogr 2004; 32: 150-157
    Google Scholar
  • 116 Dimeo FC, Tilmann MH, Bertz H, Kanz L, Mertelsmann R, Keul J. Aerobic exercise in the rehabilitation of cancer patients after high dose chemotherapy and autologous peripheral stem cell transplantation. Cancer 1997; 79: 1717-1722
    CrossrefPubMedGoogle Scholar
  • 117 Herbert V. Unproven (questionable) dietary and nutritional methods in cancer prevention and treatment. Cancer 1986; 58 (Suppl. 08) 1930-1941
    CrossrefPubMedGoogle Scholar
  • 118 Schraub S. Unproven methods in cancer: A worldwide problem. Support Care Cancer 2000; 8: 10-15
    PubMedGoogle Scholar
  • 119 Wong YN, Mitra N, Hudes G, Localio R, Schwartz JS, Wan F. et al. Survival associated with treatment vs. observation of localized prostate cancer in elderly men. JAMA 2006; 296: 2683-2693
    CrossrefPubMedGoogle Scholar